Article
Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype.
Biological psychiatry - 1 Mar 2013
Thambisetty Madhav, An Yang, Nalls Michael, Sojkova Jitka, Swaminathan Shanker, Zhou Yun, Singleton Andrew B, Wong Dean F, Ferrucci Luigi, Saykin Andrew J, Resnick Susan M
Abstract excerpt
BACKGROUND: The rs3818361 single nucleotide polymorphism in complement component (3b/4b) receptor-1 (CR1) is associated with increased risk of Alzheimer's disease (AD). Although this novel variant is associated with a small effect size and is unlikely to be useful as a predictor of AD risk, it might provide insights into AD pathogenesis. We examined the association between rs3818361 and brain amyloid deposition...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
